Clinical Trial

Efficacy and Safety of Etoricoxib/Betamethasone Combination in Acute Bursitis, Tendinitis and Synovitis

Completed Phase 3
View on ClinicalTrials.gov →
Summary
Phase III, multicenter, prospective, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of a fixed-dose combination of etoricoxib/betamethasone compared with etoricoxib alone in patients with an acute episode of bursitis, tendinitis, or synovitis affecting the shoulder, elbow, knee, or ankle.
Trial Details
NCT Number NCT07328022
Lead Sponsor Laboratorios Silanes S.A. de C.V.
Conditions Bursitis, Tendinitis, Synovitis
Enrollment 89 participants
Start Date 2025-05-14
Primary Completion 2025-08-20 (estimated)
Study Completion 2025-11-19 (estimated)
Updated on ClinicalTrials.gov 2026-01-08